Data gathered: January 21
AI Stock Analysis - Bristol-Myers Squibb (BMY)
Analysis generated November 29, 2024. Powered by Chat GPT.
Bristol Myers Squibb (BMY) is a globally recognized biopharmaceutical company. It focuses on discovering, developing, and delivering innovative medicines that help patients overcome serious diseases. The company is known for its robust pipeline of potential products and a strong portfolio of existing therapies catering to oncology, cardiovascular, immunoscience, and fibrotic diseases.
Stock Alerts - Bristol-Myers Squibb (BMY)
 |
Bristol-Myers Squibb | January 14 Job postings are down by 41% in the last couple of days. |
|
Bristol-Myers Squibb | January 7 Virginia Foxx (member of U.S. congress) is buying shares |
|
Bristol-Myers Squibb | January 6 Job postings are down by 56.4% in the last couple of days. |
|
Bristol-Myers Squibb | January 4 Over the past few months, there has been a noticeable downward trend in Job postings. |
Alternative Data for Bristol-Myers Squibb
About Bristol-Myers Squibb
The Bristol-Myers Squibb Company is an American multinational pharmaceutical company. Headquartered in New York City, BMS is one of the world's largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations.
| Price | $56.29 |
| Target Price | Sign up |
| Volume | 10,900,000 |
| Market Cap | $114B |
| Year Range | $38.61 - $59.29 |
| Dividend Yield | 4.41% |
| PE Ratio | 12.66 |
| Analyst Rating | 31% buy |
| Earnings Date | February 6 '25 |
| Industry | Drug Manufacturers |
In the news
 |
Hennion & Walsh Asset Management Inc. Has $1.34 Million Position in Bristol-Myers Squibb (NYSE:BMY)January 19 - ETF Daily News |
|
Bristol-Myers Squibb (NYSE:BMY) Shares Acquired by Accurate Wealth Management LLCJanuary 17 - ETF Daily News |
|
What is Leerink Partnrs’ Estimate for BMY Q4 Earnings?January 16 - ETF Daily News |
|
Wedmont Private Capital Has $586,000 Stock Holdings in Bristol-Myers Squibb (NYSE:BMY)January 15 - ETF Daily News |
|
4,475 Shares in Bristol-Myers Squibb (NYSE:BMY) Bought by Fiduciary Alliance LLCJanuary 15 - ETF Daily News |
|
What is Leerink Partnrs’ Forecast for BMY FY2024 Earnings?January 14 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 11.9B | 7.5B | 4.39B | 1.21B | -129M | 1.800 |
| Q2 '24 | 12.2B | 7.67B | 4.53B | 1.68B | -438M | 2.070 |
| Q1 '24 | 11.9B | 7.77B | 4.09B | -11.9B | -8.69B | -4.400 |
| Q4 '23 | 11.5B | 7.19B | 4.29B | 1.76B | 4.29B | 1.590 |
| Q3 '23 | 11B | 6.93B | 4.03B | 1.93B | 4.71B | 2.000 |
Insider Transactions View All
| Holzer Phil M filed to sell 11,760 shares at $55.6. November 5 '24 |
| Hirawat Samit filed to buy 62,109 shares at $54.7. November 5 '24 |
| BOERNER CHRISTOPHER S. filed to buy 82,672 shares at $49.8. December 7 '23 |
| BOERNER CHRISTOPHER S. filed to buy 79,384 shares at $48.9. November 30 '23 |
| Samuels Theodore R. II filed to buy 35,500 shares at $49.8. November 21 '23 |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
Johnson & JohnsonJNJ |
$147.03 0% | 45 |
 |
Eli Lilly and CompanyLLY |
$725.72 0% | 66 |
 |
PfizerPFE |
$26.3 0% | 38 |
 |
AstrazenecaAZN |
$66.6 0% | 54 |
 |
AbbVieABBV |
$171.56 0% | 53 |
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Virginia Foxx |
Jan 7, 25 | Buy | $1K - $15K |
| John James |
Sep 2, 24 | Buy | $1K - $15K |
| Rohit Khanna Democrat |
Jun 5, 24 | Sell | $15K - $50K |
Read more about Bristol-Myers Squibb (BMY) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, lobbying cost, business outlook & linkedin employees.
What is the Market Cap of Bristol-Myers Squibb?
The Market Cap of Bristol-Myers Squibb is $114B.
What is Bristol-Myers Squibb's PE Ratio?
As of today, Bristol-Myers Squibb's PE (Price to Earnings) ratio is 12.66.
When does Bristol-Myers Squibb report earnings?
Bristol-Myers Squibb will report its next earnings on February 6 '25.
What is the current stock price of Bristol-Myers Squibb?
Currently, the price of one share of Bristol-Myers Squibb stock is $56.29.
How can I analyze the BMY stock price chart for investment decisions?
The BMY stock price chart above provides a comprehensive visual representation of Bristol-Myers Squibb's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Bristol-Myers Squibb shares. Our platform offers an up-to-date BMY stock price chart, along with technical data analysis and alternative data insights.
Does BMY offer dividends to its shareholders?
Yes, Bristol-Myers Squibb (BMY) offers dividends to its shareholders, with a dividend yield of 4.41%. This dividend yield represents Bristol-Myers Squibb's commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering Bristol-Myers Squibb in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.
What are some of the similar stocks of Bristol-Myers Squibb?
Some of the similar stocks of Bristol-Myers Squibb are Johnson & Johnson, Eli Lilly and Company, Pfizer, Astrazeneca, and AbbVie.
.